Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Sargent

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Current Oncology Reports|December 3, 2010
Incorporation of biomarker assessment in novel clinical trial designs: personalizing brain tumor treatmentsEvanthia Galanis, Wenting Wu, Jann Sarkaria, et al.
Cancer|March 25, 2009
Cost implications of new treatments for advanced colorectal cancerYu-Ning Wong, Neal J Meropol, William Speier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2010
Randomized phase II trials: inevitable or inadvisable?Hui K Gan, Axel Grothey, Gregory R Pond, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2008
Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer: results from a large observational cohort study (BRiTE)Axel Grothey, Mary M Sugrue, David M Purdie, et al.
European Journal of Cancer (Oxford, England : 1990)|November 19, 2013
The role of response evaluation criteria in solid tumour in anticancer treatment evaluation: results of a survey in the oncology communityYan Liu, Saskia Litière, Elisabeth Ge de Vries, et al.
Journal of Geriatric Oncology|September 18, 2017
Challenges of conducting a prospective clinical trial for older patients: Lessons learned from NCCTG N0949 (alliance)Nadine J McCleary, Joleen Hubbard, Michelle R Mahoney, et al.
Annals of Surgical Oncology|April 15, 2006
Current issues in adjuvant treatment of stage II colon cancerThierry André, Daniel Sargent, Josep Tabernero, et al.
Journal of Clinical Epidemiology|December 18, 2010
Optimism bias leads to inconclusive results-an empirical studyBenjamin Djulbegovic, Ambuj Kumar, Anja Magazin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 21, 2007
End points in advanced colon cancer clinical trials: a review and proposalCarmen Allegra, Charles Blanke, Marc Buyse, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2012
Benefits and adverse events in younger versus older patients receiving adjuvant chemotherapy for colon cancer: findings from the Adjuvant Colon Cancer Endpoints data setJoleen Hubbard, David M Thomas, Greg Yothers, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Current Oncology Reports|December 3, 2010
Incorporation of biomarker assessment in novel clinical trial designs: personalizing brain tumor treatmentsEvanthia Galanis, Wenting Wu, Jann Sarkaria, et al.
Cancer|March 25, 2009
Cost implications of new treatments for advanced colorectal cancerYu-Ning Wong, Neal J Meropol, William Speier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2010
Randomized phase II trials: inevitable or inadvisable?Hui K Gan, Axel Grothey, Gregory R Pond, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2008
Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer: results from a large observational cohort study (BRiTE)Axel Grothey, Mary M Sugrue, David M Purdie, et al.
European Journal of Cancer (Oxford, England : 1990)|November 19, 2013
The role of response evaluation criteria in solid tumour in anticancer treatment evaluation: results of a survey in the oncology communityYan Liu, Saskia Litière, Elisabeth Ge de Vries, et al.
Journal of Geriatric Oncology|September 18, 2017
Challenges of conducting a prospective clinical trial for older patients: Lessons learned from NCCTG N0949 (alliance)Nadine J McCleary, Joleen Hubbard, Michelle R Mahoney, et al.
Annals of Surgical Oncology|April 15, 2006
Current issues in adjuvant treatment of stage II colon cancerThierry André, Daniel Sargent, Josep Tabernero, et al.
Journal of Clinical Epidemiology|December 18, 2010
Optimism bias leads to inconclusive results-an empirical studyBenjamin Djulbegovic, Ambuj Kumar, Anja Magazin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 21, 2007
End points in advanced colon cancer clinical trials: a review and proposalCarmen Allegra, Charles Blanke, Marc Buyse, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2012
Benefits and adverse events in younger versus older patients receiving adjuvant chemotherapy for colon cancer: findings from the Adjuvant Colon Cancer Endpoints data setJoleen Hubbard, David M Thomas, Greg Yothers, et al.
Pageof 5